CJC-1295 (No DAC)

Growth Hormone Signaling & Endocrine Research Pathways

Each vial contains 5mg of high-purity CJC-1295 (No DAC), a synthetic peptide studied in laboratory research for its interaction with biological pathways associated with growth hormone signaling and endocrine regulatory mechanisms.

CJC-1295 (No DAC) is a synthetic analogue of growth hormone–releasing hormone (GHRH) designed to interact with receptors involved in growth hormone signaling pathways. In scientific research environments, peptides within this class are studied for their interaction with biological systems associated with pituitary signaling, hormonal communication, and endocrine regulatory mechanisms.

Researchers investigate CJC-1295 (No DAC) in laboratory settings to better understand its interaction with pathways involved in growth hormone signaling, endocrine feedback systems, and molecular communication between the hypothalamus and pituitary gland. Experimental studies also explore how GHRH analogues influence mechanisms related to hormonal regulation and cellular signaling within endocrine pathways.

Because of these characteristics, peptides such as CJC-1295 (No DAC) are studied in experimental research focused on endocrine signaling, hormonal communication pathways, and growth hormone regulatory mechanisms.

All products are manufactured using high-purity peptide synthesis and controlled lyophilization processes to maintain stability and structural integrity for laboratory and scientific research applications.

Important Notice

This product is intended for laboratory research and scientific purposes only.

It is not approved by Health Canada, the FDA, or any other regulatory authority for human or veterinary use.
This product is not intended to diagnose, treat, cure, or prevent any disease.

By purchasing this product, customers acknowledge that it is strictly for research use only.